Researchers have developed a test that detects prostate cancer using dried blood samples in under 15 minutes.
The study, titled “Insights into Polycrystalline Microstructure of Blood Films with 3D Mueller Matrix Imaging Approach,” was conducted by Aston University in Birmingham and published in Scientific Reports.
The test analyzes crystal-like structures in dehydrated blood to identify signs of cancer, showing a 90 per cent accuracy in early trials.
Lead researcher, Igor Meglinski from Aston University’s Institute of Photonic Technologies described the development as a “breakthrough.”
He explained, “This advancement represents a substantial leap forward in personalized medicine and oncology, offering a new avenue for early detection.”
Prostate cancer is a major health issue globally and is particularly prevalent in Nigeria, where it is the most common cancer among men. The country faces high mortality rates, with 32.8 cases and 16.3 deaths per 100,000 men.
Despite this, the study did not address the test’s specific impact on Nigeria or West Africa, where late diagnosis contributes to the high mortality rate.
Currently, prostate cancer diagnosis often relies on the invasive PSA blood test followed by biopsies. This new method offers a less invasive alternative, analyzing the 3D shape and arrangement of proteins in dried blood samples. “By enabling earlier and more accurate detection, our blood test could significantly improve patient outcomes and survival rates,” Meglinski noted.
However, Matthew Hobbs, Director of Research at Prostate Cancer UK, cautioned, “The main challenge will be proving that this test provides a clear improvement over existing methods.” Larger clinical trials are needed to confirm the test’s efficacy and potential benefits.
